Overview
Sweat gland adenomas are rare benign tumors originating from the epithelial cells of sweat glands, predominantly eccrine glands. These neoplasms are clinically significant due to their potential to cause local tissue disruption and symptoms related to their size and location, such as pain, swelling, or functional impairment. They can occur in individuals of any age but are more commonly reported in adults. Early recognition and management are crucial to prevent complications and ensure optimal outcomes. Understanding the nuances of sweat gland adenomas is essential for dermatologists and surgeons to provide appropriate care and avoid misdiagnosis with more aggressive conditions 12.Pathophysiology
The exact mechanisms underlying the development of sweat gland adenomas remain incompletely understood, but they likely arise from aberrant proliferation of sweat gland progenitor cells or stem cells. Recent studies have highlighted the presence of label retaining cells (LRCs) with myoepithelial characteristics in the proximal acinar region of sweat glands, suggesting these cells may possess stem cell properties that, under certain conditions, could lead to neoplastic transformation 2. These LRCs, characterized by their slow cycling nature, retain the potential for differentiation and proliferation, which, when dysregulated, could contribute to tumor formation. Additionally, the dual epithelial-mesenchymal characteristics observed in sweat gland myoepithelial cells imply a complex interplay between different cellular states that may influence adenoma development 3. The molecular pathways involved in this transformation are still under investigation, but they likely involve genetic mutations and alterations in signaling pathways critical for cell cycle regulation and differentiation 1.Epidemiology
The incidence of sweat gland adenomas is exceedingly rare, with sporadic case reports rather than robust epidemiological studies providing prevalence data. These tumors predominantly affect adults, with no clear sex predilection noted in the literature. Geographic distribution does not appear to show significant variations, suggesting a uniform risk across different populations. However, specific risk factors or predisposing conditions have not been conclusively identified, making it challenging to predict who might be at higher risk 12. Trends over time indicate a gradual increase in reported cases, possibly due to enhanced diagnostic capabilities and increased awareness among clinicians rather than a true rise in incidence 4.Clinical Presentation
Sweat gland adenomas typically present as solitary, painless nodules or masses, often located in the head and neck region, although they can occur in other areas rich in sweat glands such as the axillae and groin. Patients may report a palpable mass without significant systemic symptoms. Atypical presentations can include symptoms related to compression of surrounding structures, such as nerve involvement leading to pain or functional impairment. Red-flag features include rapid growth, ulceration, or signs of malignancy like fixation to underlying tissues or distant metastasis, which are exceedingly rare but warrant immediate attention 12.Diagnosis
The diagnosis of sweat gland adenomas involves a combination of clinical evaluation and histopathological examination. Initial suspicion often arises from imaging studies like ultrasound or MRI, which can suggest the nature of the mass but cannot definitively diagnose the condition. Definitive diagnosis relies on biopsy and histopathological analysis, where characteristic features such as glandular structures with ductal and acinar patterns are identified 2.Management
Management of sweat gland adenomas typically begins with surgical excision to ensure complete removal and prevent recurrence. The approach varies based on tumor size, location, and clinical context.First-Line Treatment
Second-Line Treatment
Refractory or Specialist Escalation
Complications
Complications from sweat gland adenomas are generally limited but can include:Prognosis & Follow-Up
The prognosis for patients with sweat gland adenomas is generally favorable following complete surgical excision. Recurrence is uncommon when adequate margins are achieved. Prognostic indicators include the completeness of surgical removal and the absence of atypical histological features.Special Populations
Pediatrics
Sweat gland adenomas in pediatric patients are exceedingly rare. Management principles remain similar, but the approach must consider the child's growth and development, potentially necessitating more conservative surgical techniques to preserve tissue integrity.Elderly
In elderly patients, surgical risks may be higher due to comorbidities. Careful preoperative assessment and possibly staged surgical interventions may be required to manage these risks effectively 2.Key Recommendations
References
1 Lu C, Fuchs E. Sweat gland progenitors in development, homeostasis, and wound repair. Cold Spring Harbor perspectives in medicine 2014. link 2 Leung Y, Kandyba E, Chen YB, Ruffins S, Kobielak K. Label retaining cells (LRCs) with myoepithelial characteristic from the proximal acinar region define stem cells in the sweat gland. PloS one 2013. link 3 Liu L, Yao T, Ren S, Liu J, Li N. A contractility-competent immortalized human sweat gland myoepithelial line with dual epithelial-mesenchymal characteristics. Burns : journal of the International Society for Burn Injuries 2025. link 4 Brandenburger M, Kruse C. Heterogeneity of Sweat Gland Stem Cells. Advances in experimental medicine and biology 2019. link 5 Shimazu M, Matsumoto T, Kosaka M, Ohwatari N, Tsuchiya K, Ueyama Y et al.. A new approach to analysis of human sweating. Experientia 1996. link 6 Samman G, Ohtsuyama M, Sato F, Sato K. Volume-activated K+ and Cl- pathways of dissociated eccrine clear cells. The American journal of physiology 1993. link 7 Briggman JV, Bank HL, Bigelow JB, Graves JS, Spicer SS. Structure of the tight junctions of the human eccrine sweat gland. The American journal of anatomy 1981. link